Status:
UNKNOWN
The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes
Lead Sponsor:
Ural State Medical University
Conditions:
Neurotrophic Ulcers
Burns
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
In Russia the treatment nonhealing skin defects often limited to surgical interventions, despite having developed modern methods of treatment of non-healing ulcers and other skin imperfections. During...
Eligibility Criteria
Inclusion
- The presence of non-healing ulcer at least a month, an area of not less than 3 cm2 or smaller area of deep defects;
- Availability of burns II or III level;
- Epidermolysis bullosa;
- Availability of post-burn scars
- Defects in the skin after surgery
Exclusion
- Acute and chronic diseases in the acute stage;
- Autoimmune diseases of connective tissue (collagen);
- Immunodeficiency states;
- System of inflammatory diseases of the skin;
- Conduct an aggressive corticosteroid therapy;
- Acute coronary syndrome;
- Acute disorders of cerebral circulation;
- Availability of local inflammation in the acute stage;
- Pregnancy;
- Breast-feeding.
- Positive results of the following tests: Anti-HIV-1 and -2, HIV-1Ag, anti-HTL VI and-II, anti-HbcorAg, HBs-Ag, anti-HCV, anti-CMV, anti-Toxoplasma gondii, RW, Neisseria gonorrheae, Chlamydia.
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01884831
Start Date
February 1 2014
End Date
July 1 2018
Last Update
December 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ural State Medical Academy
Yekaterinburg, Russia, 620028